Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • kmpphd
    Junior Member
    • Dec 2010
    • 5

    #1

    Cluster formation/ddNTP blocking

    I have a ddNTP question based on the Bentley et al NATURE 2008 Article, “Accurate whole human genome sequencing using reversible terminator chemistry."

    In the Supplementary Information, page 4, “Processing of clusters for single read experiments,” it is stated “ All exposed 3’-OH termini of DNA…were blocked by dideoxy chain termination using a terminal transferase and ddNTPs.”

    Again on page 4, “Processing of clusters for paired read experiments,” it is stated “Clusters were 3’-dephosphorylated using T4 polynucleotide kinase…”

    Following the final round of bridge amplification to form the clusters, my assumption is that ddNTPs with 3’-monophosphates were used for blocking (ddCTP specifically given the sequences of the primers used?). The flow cell-fixed primers that had been treated with USER would already have
    3'-monophosphate groups, so essentially all exposed 3’-hydroxyls are capped with 3’-phosphates. Treatment with T4 polynucleotide kinase then converts all 3’-phosphates to 3’-hydroxyls, allowing extension to take place.

    Is my assumption correct?
  • kmpphd
    Junior Member
    • Dec 2010
    • 5

    #2
    Follow up to my ddNTP question. I just skimmed through the Bentley et al patent application entitled "Method for Sequencing a Polynucleotide Template," Patent Application Number 20110009276. In it is referenced WO 2004/070005, "Double Ended Sequencing."

    The latter patent states in part “The reversibly blocked primers should be blocked with different chemical groups. By choosing the appropriate method of deblocking, one primer may be deblocked without affecting the blocking groups of the other primers. In a preferred embodiment, the blocking group is P04. That is, the second primer is blocked by P04 and deblocking is accomplished by T4 polynucleotide kinase (utilizing its 3'-phosphatase activity) or calf-intestinal alkaline phosphatase (CIAP) or any suitable phosphatase.”

    Still not a confirmation of what is going on within the cBot but it is consistent with the Bentley paper.

    Comment

    Latest Articles

    Collapse

    • SEQadmin2
      Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
      by SEQadmin2



      Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

      Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
      ...
      10-14-2026, 09:55 AM
    • SEQadmin2
      New Genomics Technologies Take Aim at Long-Standing Limits
      by SEQadmin2


      Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

      We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
      ...
      09-28-2026, 10:25 AM

    ad_right_rmr

    Collapse

    News

    Collapse

    Topics Statistics Last Post
    Started by SEQadmin2, 10-22-2026, 11:13 AM
    0 responses
    51 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-22-2026, 10:48 AM
    0 responses
    38 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-15-2026, 10:52 AM
    0 responses
    46 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-14-2026, 05:39 AM
    0 responses
    46 views
    0 reactions
    Last Post SEQadmin2  
    Working...